You are here

insulin

$35 monthly insulin cap: Republicans decry how White House, Dems plan to pay for it

Endpoints

Thu, 03/31/22 - 10:35 am

U.S. Senate to Take Up Proposed $35 Insulin Cap this Spring

BioSpace

Mon, 03/28/22 - 07:54 pm

'March-in' battles heat up as nonprofits petition HHS on 6 drugs as earlier petition awaits decision

Endpoints

Mon, 03/28/22 - 10:08 am

Gilead Sciences

Insulin price caps on the horizon as Senate leader plans vote

Pharmaforum

Wed, 03/23/22 - 10:33 am

Civica aims to launch low-cost insulin in U.S. by 2024

Yahoo/Reuters

Thu, 03/3/22 - 10:17 am

Viatris yanks one batch of diabetes med Semglee because of missing label risks

Fierce Pharma

Fri, 01/21/22 - 11:00 am

Five Takeaways from the Big Three PBMs’ 2022 Formulary Exclusions

Drug Channels

Wed, 01/19/22 - 10:58 am

Express Scripts

Novo Nordisk comes out clean in $1.8B investor lawsuit alleging insulin misdirection

Fierce Pharma

Mon, 01/17/22 - 10:55 am

Biden touts drug cost measures in spending bill

Beckers Hospital Review

Tue, 12/7/21 - 11:44 pm

Build Back Better Act

Novo Nordisk, Sanofi and Eli Lilly cut insulin prices and lose share in China's latest cost squeeze

Fierce Pharma

Mon, 11/29/21 - 10:55 pm

China’s insulin plans will hit 2022 revenues, says Novo Nordisk

Pharmaforum

Fri, 11/26/21 - 08:54 pm

value-based procurement

What does the Build Back Better Act actually mean for the health care industry?

Stat

Tue, 11/23/21 - 08:46 pm

Build Back Better Act

Democrats’ major drug pricing reforms clear a hurdle in the House

Stat

Fri, 11/19/21 - 10:53 am

Viatris launched two versions of its interchangeable insulin biosimilar. Why?

Fierce Pharma

Tue, 11/16/21 - 10:29 pm

Eli Lilly ordered to pay royalties on blockbuster diabetes drugs, though exact damages are unclear

Endpoints

Thu, 10/21/21 - 11:22 pm

Eli Lilly to reduce list price of Insulin Lispro injection by an additional 40% from Jan. 1, restoring it to 2008 levels

Marketwatch

Tue, 09/28/21 - 11:23 pm

Novo Nordisk settles insulin pricing suit for $100M

Endpoints

Mon, 09/27/21 - 10:56 am

House committee questions Eli Lilly, Sanofi and Novo Nordisk as insulin prices remain 'unacceptably high'

Endpoints

Fri, 08/20/21 - 12:31 pm

How This Historic FDA Approval Benefits Viatris

Motley Fool

Wed, 08/4/21 - 10:57 am

interchangeable biosimilars

FDA approves first interchangeable biosimilar

Biopharma Reporter

Thu, 07/29/21 - 11:19 am

interchangeable biosimilars

Pages